Biocompatible Membrane Composite for Implantable Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable devices often trigger a foreign body response, leading to the formation of foreign body giant cells that restrict vascularization and access to oxygen, nutrients, and analytes, hindering the function of implanted cells and devices.
Innovation Solution
A biocompatible membrane composite with distinct layers, including a mitigation layer with solid features and a vascularization layer with larger pore sizes, designed to minimize foreign body giant cell formation and promote vascularization, is used to create an environment that allows implanted cells to survive and function effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a biocompatible membrane is used to prevent cell passage, then cell containment is improved, but vascularization is hindered
Solution Approach 1:
The membrane is divided into multiple layers with different pore sizes: a first layer with smaller pores (1-9 microns) for cell containment and a second layer with larger pores (>9 microns) for vascularization. This segmentation allows each layer to perform its specific function without interfering with the other, resolving the contradiction between cell containment and vascularization.
Solution Approach 2:
Different regions of the membrane have different pore sizes tailored to specific functions. The first layer has small pores localized for preventing cell passage, while the second layer has large pores localized for promoting blood vessel growth. This local differentiation of properties allows simultaneous achievement of cell containment and vascularization.
2Reliability
If foreign body giant cells form at the interface, then immune response is triggered, but access to oxygen and nutrients is restricted
Solution Approach 1:
The second layer with large pores acts as an intermediary zone between the implanted device and the surrounding tissue. It facilitates the formation of an immune-isolating capsule while simultaneously promoting vascularization through the large pores, allowing oxygen and nutrients to reach the implanted cells without triggering harmful immune responses.
Solution Approach 2:
The use of porous materials with specifically controlled pore sizes enables selective passage of substances. The large pores in the second layer allow passage of oxygen, nutrients, and analytes while the membrane structure maintains immune isolation, thus supporting cell survival and function without compromising immune response control.
3Object-generated harmful factors
If pore size is increased to allow vascularization, then blood vessel formation is improved, but cell containment is compromised
Solution Approach 1:
The membrane is segmented into two distinct layers: the first layer with small pores (1-9 microns) that prevents cell passage and maintains containment, and the second layer with large pores (>9 microns) that promotes vascularization. This segmentation resolves the contradiction by assigning different pore size requirements to different functional layers.
Solution Approach 2:
The solution moves from a single-dimensional pore size parameter to a multi-dimensional structure with layered architecture. By adding the layer dimension, the system can have small pores in one layer and large pores in another layer, simultaneously achieving cell containment and vascularization without compromise.
Data Source
AI summary
A biocompatible membrane composite that can provide an environment that is able to mitigate or tailor the foreign body response is provided. The membrane composite contains a mitigation layer and a vascularization layer. A reinforcing component may optionally be included to provide support to and prevent distortion of the biocompatible membrane composite in vivo. The mitigation layer may be bonded (e.g., point bonded or welded) or adhered (intimately or discretely) to an implantable device and/or cell system. The biocompatible membrane composite may be used as a surface layer for implantable devices or cell systems that require vascularization for function but need protection from the host's immune response, such as the formation of foreign body giant cells. The biocompatible membrane composite may partially or fully cover the exterior of an implantable device or cell system. The mitigation layer is positioned between the implantable device or bioactive scaffold and the vascularization layer.